Patents by Inventor Ivan V. Korendovych

Ivan V. Korendovych has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides for prevention of HIV infection
    Patent number: 10695399
    Abstract: Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: June 30, 2020
    Assignee: SYRACUSE UNIVERSITY
    Inventor: Ivan V. Korendovych
  • PEPTIDES FOR PREVENTION OF HIV INFECTION
    Publication number: 20200054710
    Abstract: Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
    Type: Application
    Filed: November 1, 2019
    Publication date: February 20, 2020
    Applicant: SYRACUSE UNIVERSITY
    Inventor: Ivan V. Korendovych
  • Peptides for prevention of HIV infection
    Patent number: 10512666
    Abstract: Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: December 24, 2019
    Assignee: SYRACUSE UNIVERSITY
    Inventor: Ivan V. Korendovych
  • PEPTIDES FOR PREVENTION OF HIV INFECTION
    Publication number: 20190038702
    Abstract: Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
    Type: Application
    Filed: July 27, 2018
    Publication date: February 7, 2019
    Applicant: SYRACUSE UNIVERSITY
    Inventor: Ivan V. Korendovych